China National Accord Medicines Corporation: Nominee Statement and Commitment (Jiang Bailin)
China National Accord Medicines Corporation: Company bylaws (revised June 2024).
China National Accord Medicines Corporation: Nominee Statement and Commitment (Li Honghai)
China National Accord Medicines Corporation: Announcement of the resolution of the third extraordinary meeting of the ninth board of directors in 2024.
China National Accord Medicines Corporation: Statement and commitment of independent director candidate (Su Weiwei).
China National Accord Medicines Corporation: Statement and Pledge of Independent Director Candidate (Li Honghai)
China National Accord Medicines Corporation: Nominee's Statement and Commitment (Bi Yalin)
China National Accord Medicines Corporation: Announcement of the resolution of the second extraordinary meeting of the ninth supervisory board in 2024.
China National Accord Medicines Corporation: Statement and Commitment of Independent Director Candidate (Bi Yalin)
China National Accord Medicines Corporation: Nominee Statement and Commitment (Su Weiwei)
China National Accord Medicines Corporation: Statement and Commitment of Independent Director Candidate (Jiang Bailing)
China National Accord Medicines Corporation: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
China National Accord Medicines Corporation: Announcement of the implementation of equity distribution in 2023.
China National Accord Medicines Corporation: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
China National Accord Medicines Corporation: Legal Opinions of the 2023 Annual General Meeting of Shareholders
China National Accord Medicines Corporation: Company 2023 ESG Report
China National Accord Medicines Corporation: Announcement of Supervisory Board Resolutions
China National Accord Medicines Corporation: Announcement of Board Resolutions
China National Accord Medicines Corporation: 2024 First Quarter Report
Sinopharm Consistency: 000028 Sinopharm Investor Relations Management Information 20240422
No Data